Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

US State Bill Tracker

Delaware Bills

Cannabis, kratom and 7-OH proposals, with recorded dates, pending status and past outcomes.

3 of 3 tracked bills

  • Kratom
    Enacted
    HS1 for HB332

    Kratom Consumer Protection Act — enacted substitute

    Session: 2026

    1. IntroducedJun 11, 2026 (done)
    2. PassedDate TBC (done)
    3. SignedSep 8, 2026 (done)
    4. Law in effectSep 8, 2026 (done)

    · Signed; effective the same day.

    Volume 85 Chapter 478, replaces HB332; signed and effective 8 September 2026.

  • Kratom
    Superseded by a new draft
    HB 332

    Kratom Consumer Protection Act

    Session: 2026

    1. IntroducedMar 26, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Replaced by HS1 for HB332.

    Original superseded; HS1 for HB332 became Chapter 478. Do not treat original bill text as enacted.

  • Kratom
    Superseded by a new draft
    SB 262

    Uniform Controlled Substances Act amendments

    Session: 2026

    1. IntroducedMar 18, 2026 (done)
    2. PassedNext step (current)
    3. Signed— (upcoming)
    4. Law in effect— (upcoming)

    · Replaced by SS1 for SB262.

    Original superseded by SS1 for SB262. Successor committee history does not establish current October pendency; no enactment verified.